Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study
Author:
Funder
Fondazione Bambino Gesù Onlus
Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology and Child Health
Link
https://link.springer.com/content/pdf/10.1007/s00467-021-05175-9.pdf
Reference32 articles.
1. Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61–74
2. Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM (2016) Anti-CD20 antibodies for idiopathic nephrotic syndrome in children. Clin J Am Soc Nephrol 11:710–720
3. Heybeli C, Erickson SB, Fervenza FC, Hogan MC, Zand L, Leung N (2020) Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfaa133
4. Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T (2013) Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome? Pediatr Nephrol 28:447–451
5. Kronbichler A, Windpessl M, Pieringer H, Jayne DRW (2017) Rituximab for immunologic renal disease: what the nephrologist needs to know. Autoimmun Rev 16:633–643
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Belimumab in the treatment of systemic lupus erythematosus with juvenile onset: Results of a single-center retrospective study;Rheumatology Science and Practice;2024-09-02
2. Medical practice of focal segmental glomerulosclerosis (FSGS);Japanese journal of pediatric nephrology;2024
3. Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches;Seminars in Nephrology;2023-11
4. Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis;Frontiers in Immunology;2023-09-19
5. Immunosuppressive Agent Options for Primary Nephrotic Syndrome: A Review of Network Meta-Analyses and Cost-Effectiveness Analysis;Medicina;2023-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3